US EditionAntimicrobial resistance and beta-lactamase gene distribution among clinical isolates: a two-year cohort study - AMR Insights
Summary by AMR Insights
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Antimicrobial resistance and beta-lactamase gene distribution among clinical isolates: a two-year cohort study - AMR Insights
A study of 2,098 patients found an evenly distributed sample, with 51.8% inpatients and 47.2% outpatients. The majority were females, with 58.5% aged 41-80 years. Urine samples produced 72.9% bacterial isolates. Between 2022 and 2023, healthcare facility admission rates increased, while outpatient walk-in numbers decreased. Antimicrobial resistance tests showed Imipenem and Tigecycline were effective, but Norfloxacin and Cotrimoxazole had notabl…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
